Radx tech II projects 13356 & 13464: rapid, point of care, multiplex covid-19 and flu a & b antigen assay and reader
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92021C00027
- Awardee
-
Princeton Biomeditech Corp UEI KWPPNEUVY865
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,062,372
Award facts
- Contract value 100% obligated
- $10,062,372.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Monmouth Junction, South Brunswick Township, NJ 08852, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$37,628 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $10,100,000 |
About this award
Princeton Biomeditech Corp was awarded a definitive, firm fixed price contract valued at $10,062,372.12 by the Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute. The contract is for RADX TECH II PROJECTS 13356 & 13464, which involves developing and delivering a rapid, point-of-care multiplex assay and reader to simultaneously detect COVID-19 and influenza A & B antigens. Work will be performed in Monmouth Junction, New Jersey through September 2023. No set-aside designation was specified. As a minority-owned, Asian-Pacific American-owned manufacturer of diagnostic products, Princeton Biomeditech Corp will leverage its experience producing over 70 rapid tests to address the need for improved coronavirus and flu detection under this contract supporting the National Institutes of Health's pandemic preparedness efforts.
Quick answers
Who was awarded contract 75N92021C00027?
75N92021C00027 was awarded to Princeton Biomeditech Corp by National Heart Lung and Blood Institute (National Institutes of Health) on September 30, 2021.
How much is contract 75N92021C00027 worth?
The government has obligated $10,062,372 on 75N92021C00027.
Was contract 75N92021C00027 competed?
The extent of competition for 75N92021C00027 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award